Erratum: Expression of the interferon-α/β-inducible MxA protein in brain lesions of subacute sclerosing panencephalitis (SSPE) (Journal of the Neurological Sciences (2004) 223 (113-119) PII: S0022-510X(04)00127-3 and DOI: 10.1016/j.jns.2004.04.029);Expression of the interferon-α/β-inducible MxA protein in brain lesions of subacute sclerosing panencephalitis

Journal of the Neurological Sciences

Volumn 223, Issue 2, 2004, Pages 113-119

  Ogata, Seiko ^a   Ogata, Akihiko ^a,b   Schneider Schaulies, Sybille ^a   Schneider Schaulies, Jürgen ^a  

^a Inst F Virologie Immunbiologie   (Germany)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Measles virus; MxA; Subacute sclerosing panencephalitis (SSPE)

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; MYXOVIRUS RESISTANCE PROTEIN A; PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BRAIN INJURY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOID CELL; MEASLES VIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SCHOOL CHILD; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

EID: 4444281133     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.10.015     Document Type: Erratum

References (49)

1. ter Meulen V., Stephenson J.R., Kreth H.W. Subacute sclerosing panencephalitis. Fraenkel-Conrat H., Wagner R.R. Comprehensive Virology. vol. 18:1983;105-159 Plenum, New York
2. Schneider-Schaulies S., Schneider-Schaulies J., Dunster L.M., ter Meulen V. Measles virus gene expression in neural cells. Billeter M.A., Ter Meulen V. Current Topics of Microbiology and Immunology (CTMI). vol. 191:1995;101-116
3. Baczko K., Liebert U.G., Billeter M.A., Cattaneo R., Budka H., ter Meulen V. Expression of defective measles virus genes in brain tissues of patients with subacute sclerosing panencephalitis. J. Virol. 59:1986;472-478
4. Cattaneo R., Rebmann G., Schmid A., Bczko K., ter Meulen V., Billeter M.A. Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J. 6:1987;681-687
5. Liebert U.G., Baczko K., Budka H., ter Meulen V. Restricted expression of measles virus proteins in brains from cases of subacute sclerosing panencephalitis. J. Gen. Virol. 67:1986;2435-2444
6. Schneider-Schaulies S., Liebert U.G., Baczko K., Cattaneo R., Billeter M.A., ter Meulen V. Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats. Virology. 171:1989;525-534
7. Schneider-Schaulies S., ter Meulen V. Molecular aspects of measles virus induced central nervous system diseases. Roos R.P. Molecular Neurovirology. 1992;419-449 Humana Press, Totowa, New Jersey
8. McQuaid S., Campbell R., Isserte S., Cosby S.L. Leukaemia inhibitory factor mRNA is expressed in the brains of patients with subacute sclerosing panencephalitis. J. Neuroimmunol. 77:1997;57-62
9. Nagano I., Nakamura S., Yoshioka M., Onodera J., Kogure K., Itoyama Y. Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology. 44:1994;710-715
10. Schneider-Schulies J., Schneider-Schaulies S., ter Meulen V. Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology. 195:1993;219-228
11. Ponten A., Sick C., Weeber M., Haller O., Kochs G. Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J. Virol. 71:1997;2591-2599
12. Schneider-Schaulies S., Schneider-Schaulies J., Schuster A., Bayer M., Pavlovic J., Ter Meulen V. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 69:1994;6910-6917
13. Schuster A., Johnston I.C.D., Das T., Banerjee A.K., Pavlovic J., ter Meulen V., et al. Expression of the human MxA protein is associated with hyperphosphorylation of the VSV-P protein in human neural cells. Virology. 220:1996;241-245
14. Staeheli P. Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38:1990;147-200
15. Staeheli P., Pitossi F., Pavlovic J. Mx proteins: GTPases with antiviral activity. Trends Biochem. Sci. 3:1993;268-272
16. Horisberger M.A. Interferon-induced human protein MxA is a GTPase which binds transiently to cellular proteins. J. Virol. 66:1992;4705-4709
17. Horisberger M.A., Staeheli P., Haller O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. U. S. A. 80:1983;1910-1914
18. Pavlovic J., Staeheli P. The antiviral potentials of Mx proteins. J. Interf. Res. 11:1991;215-219
19. Richter M.F., Schwemmle M., Herrnann C., Wittinghofer A., Staeheli P. Interferon-induced MxA protein. GTP binding and GTP hydrolysis properties. J. Biol. Chem. 270:1995;13512-13517
20. Schwemmle M., Weining K.C., Richter M.F., Schumacher B., Staeheli P. Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology. 206:1995;545-554
21. Pavlovic J., Zürchner T., Haller O., Staeheli P. Resitence to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:1990;3370-3375
22. Zürcher T., Pavlovic J., Staeheli P. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 11:1992;1657-1661
23. Frese M., Kochs G., Meier-Dieter U., Siebler J., Haller O. Human MxA protein inhibits Tick-Borne Thogoto virus but not Dhori virus. J. Virol. 69:1995;3904-3905
24. Staeheli P., Pavlovic J. Inhibition of vesicular stomatits virus mRNA synthesis by human MxA protein. J. Virol. 65:1991;4498-4501
25. Landis H., Simon-Jödicke A., Klöti A., Di Paolo C., Schnorr J.J., Schneider-Schaulies S., et al. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 72:1998;1516-1522
26. Schnorr J.J., Schneider-Schaulies S., Simon-Jödicke A., Pavlovic J., Horisberger M.A., ter Meulen V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J. Virol. 67:1993;4760-4768
27. Nakayama M., Nagata K., Kato A., Ishihama A. Interferon-inducible mouse Mx1 protein that confers resistance to influenza virus is a GTPase. J. Biol. Chem. 266:1991;21404-21408
28. Zürcher T., Pavlovic J., Staeheli P. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J. Virol. 66:1992;5059-5066
29. Meier E., Kunz G., Haller O., Arnheiter H. Activity of rat Mx proteins against a rhabdovirus. J. Virol. 64:1990;6263-6269
30. Kanerva M., Melén K., Vaheri A., Julkunen I. Inhibition of Puumala and Tula-Hantavirus in vero cells by MxA protein. Virology. 224:1996;55-62
31. Fäh J., Pavlovic J., Burg G. Expression of MxA protein in inflammatory dermatoses. J. Histochem. Cytochem. 43:1995;47-52
32. Ronni T., Melen K., Malygin A., Julkunnen I. Control of IFN-inducible MxA gene expression in human cells. J. Immunol. 150:1993;1715-1726
33. Baczko K., Lampe J., Liebert U.G., Brinckmann U., Meulen V.ter., Pardowitz I., et al. Clonal expansion of hypermutated measles virus in a SSPE brain. Virology. 197:1993;188-195
34. Bancher C., Leitner H., Jellinger K., Eder H., Liszka U., Wegiel J., et al. On the expression between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis. Neurobiol. Aging. 17:1996;527-533
35. Iwasaki Y., Sako K., Tsunoda I., Ohara Y. Phenotypes of mononuclear cell infiltrates in human central nervous system. Acta Neuropathol. 85:1993;653-657
36. Ogata A., Czub S., Ogata S., Cosby S.L., McQuaid S., Budka H., et al. Absence of measles virus receptor (CD46) in lesions of subacute sclerosing panencephalitis. Acta Neuropathol. 94:1997;444-449
37. Cordell J.L., Falini B., Erber W.N., Ghosh A.K., Abdulaziz Z., Macdonald S., et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32:1984;219-229
38. Mason D.Y., Sammons R. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. J. Clin. Pathol. 31:1978;454-460
39. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981a;577-580
40. Mibayashi M., Nakad K., Nagata K. Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol. Immunol. 46:2002;29-36
41. Allen I.V., McQuaid S., McMahon J., Kirk J., McConnel R. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination. J. Neuropathol. Exp. Neurol. 55:1996;471-480
42. Iwasaki Y., Koprowski H. Cell to cell transmission of virus in the central nervous system. Lab. Invest. 31:1974;187-192
43. Forster J., Schweizer M., Schumacher R.F., Kaufmehl K., Lob S. MxA protein in infants and children with respiratory tract infection. Acta Paediatr. 85:1996;163-167
44. Vallittu A.-M., Halminen M., Peltoniemi J., et al. Neutralizing antibodies reduce MxA protein induction in interferon-beta-1a-treated MS patients. Neurology. 58:2002;1786-1790
45. Yamada T. Further observation on MxA-positive Lewy bodies in Parkinson's disease brain tissues. Neurosci. Lett. 195:1995;41-44
46. Yamada T., Horisberger M.A., Kawaguchi N., Moroo I., Toyoda T. Immunohistochemistry using antibodies to a-interferon and its induced protein, MxA, in Alzheimer's and Parkinson's disease brain tissues. Neurosci. Lett. 181:1994;61-64
47. Gascon G., Yamani S., Crowell J., Stigsby B., Nester M., Kanaan I., et al. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev. 15:1993;346-355
48. Huttenlocher P.R., Picchietti D.L., Roos R.P., Cashmen N.R., Horowitz B., Horowitz M.S. Intrathecal interferon in subacute sclerosing panencephalitis. Ann. Neurol. 19:1986;303-305
49. Yoshioka H., Nishimura O., Nakagawa M., Ochi M., Takeuchi Y., Tominaga M., et al. Administration of human leukocyte interferon to patients with subacute sclerosing panencephalitis. Brain Dev. 11:1989;302-307